ARCHIVES

Gemcitabine Improves DFS In Resected Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Leukemia Society, Glaxo Award Fellowship; Penn Leads CLF; Wight Heads Charity

September 10, 1999

Group Chairman Balk At Board’s Recommendations

February 15, 1980

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991

Reports On AACR Scientific Sessions

May 21, 1976

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

HHS, NIH Prepare for Government Shutdown

September 20, 2013